Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

E. Hernández, Jaime; Adiga, Raghavendra; W. Armstrong, Robert; A. Bazan, José; Bonilla, Hector; S. Bradley, John; Dretler, Robin; G. Ison, Michael; E. Mangino, Julie; R. Maroushek, Stacene; K. Shetty, Avinash; Wald, Anna; Ziebold, Christine; Elder, Jenna; S. Hollister, Alan; Sheridan, William; behalf of the eIND Peramivir Investigators, on

doi:10.1093/cid/cir001

Public

Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

Published in Clinical Infectious Diseases • Feb 23, 2011

Authors:

Jaime E. Hernández

Raghavendra Adiga

Robert W. Armstrong

Abstract

BACKGROUND: Peramivir, an investigational intravenous neuraminidase inhibitor in Phase 3 trials for hospitalized patients, was made available during the 2009 H1N1 influenza pandemic under the Emergency Investigational New Drug (eIND) regulations. We describe the clinical characteristics and outcomes...

Subject

Medicine

Oseltamivir

Neuraminidase inhibitor

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!